TG Therapeutics | TGTX - Trade Debtors

Stock Price
28.86
Daily Change
1.10 3.96%
Monthly
-4.88%
Yearly
-12.78%
Q1 Forecast
28.52

TG Therapeutics reported $265.38M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
Amgen USD 8.49B 211M Sep/2025
Ardelyx USD 76.61M 14.06M Sep/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
Bayer EUR 14.91B 2.73B Sep/2025
Biogen USD 1.85B 234M Sep/2025
Corcept Therapeutics USD 69.63M 5.06M Sep/2025
Dynavax Technologies USD 73.34M 16.79M Jun/2025
Gilead Sciences USD 5.1B 314M Sep/2025
J&J USD 17.61B 235M Sep/2025
Novartis USD 8.98B 192M Sep/2025
PTC Therapeutics USD 203.07M 6.94M Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
TG Therapeutics USD 265.38M 33.86M Sep/2025
Vertex Pharmaceuticals USD 1.95B 52.9M Sep/2025